Non-Cytotoxic Agarose/Hydroxyapatite Composite Scaffolds for Drug Release

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Large bone defects necessitate advanced implants or scaffolds for effective healing.
• Scaffolds must guide cell growth, differentiation, and vascularization for successful bone regeneration.

Purpose of the Study:

• To develop a novel agarose-hydroxyapatite composite scaffold.
• To characterize the scaffold's properties and assess its potential as a drug delivery system.

Main Methods:

• In situ incorporation of hydroxyapatite into agarose gels.
• Characterization of scaffold composition, porosity, mechanical properties, and biocompatibility using MTT assays.
• Loading scaffolds with model drugs (ATP, suramin) to evaluate drug release kinetics.

Main Results:

• A pure phase of carbonated hydroxyapatite was identified in the scaffolds with pores up to several hundred micrometers.
• Lyophilized composites exhibited elastic moduli up to 2.8 MPa.
• Scaffolds demonstrated biocompatibility with human mesenchymal stem cells and osteosarcoma cells.
• Sustained drug release over four days was observed for ATP and suramin.

Conclusions:

• The developed agarose-hydroxyapatite composite scaffold is a promising biomaterial for bone defect repair.
• The scaffold functions as both a structural matrix and a controlled drug release system.
• This composite material holds potential for guided cell differentiation and enhanced bone regeneration.